Announced
Completed
Financials
Tags
Acquisition
Friendly
Private
Majority
Single Bidder
chromatography hardware
Electronic Components and Equipment
biotech
United States
Completed
Synopsis
Sartorius Stedim Biotech, a provider of cutting-edge products and services for the development, quality assurance and production processes of the biopharmaceutical industry, completed the acquisition of Danaher's Select Life Science Platform Businesses, which provide chromatography hardware and resins, for $825m. “The portfolio proposed for acquisition represents an excellent strategic fit with Sartorius Stedim Biotech. With the chromatography hardware and resins and the microcarrier businesses, we broaden our strong bioprocessing offering, particularly in the downstream area. We look very much forward to welcoming the new teams to Sartorius and to jointly combine our capabilities for the benefit of our biopharma and life science customers,” Joachim Kreuzburg, Sartorius Stedim Biotech Chairman of the Board and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.